Another Sunnybrook update: risk for metastasis on active surveillance

The Sunnybrook Group from the University of Toronto in Canada have just provided us with yet another update on the outcomes of their cohort of 980 patients managed initially on active surveillance and dating back to 1996. … READ MORE …

“Therapeutic illusion” and prostate cancer care

In this week’s New England Journal of Medicine there is what your sitemaster considers to be a highly informative article on what is known as “therapeutic illusion” and its impact on clinical practice. … READ MORE …

Can a new logistical approach radically change surgical options for patients?

One of the things we have been asked multiple times over the years is “What does it cost to have” a radical prostatectomy, or a penile implant, or some other prostate cancer-related procedure. Usually, we have had some idea, but it can be near to impossible to get precise, total costs for such procedures — even from your local hospital. … READ MORE …

To screen or not to screen: an Australian “discrete choice experiment”

The question of whether men should be regularly screened for risk of prostate cancer through the use of the PSA test is (at least) controversial … READ MORE …

Decision aids and patient choice of therapy: a randomized, controlled, clinical trial

A new paper in BJU International reports data about the development of an appropriate decision aid and the results of a randomized, controlled, clinical trial designed to investigate the effects of use of that decision aid (as opposed to “usual care”) on patients’ selection of radiation therapy as opposed to radical prostatectomy for localized disease. … READ MORE …

How young men have thought about treatment options for Gleason 6 prostate cancer

A new study based on data from nearly 500 patients gives us some insight into how a selected group of men less than 50 years of age were thinking about treatment for prostate cancer between 2001 and 2005. Whether one would get the same results for a similar group of patient diagnosed today is a good question. … READ MORE …

Use of CAM among rural prostate cancer patients in one US state

There is significant use of a variety of forms of complementary and alternative forms of medicine (CAM) among patients with localized prostate cancer. A new study in the Journal of Community Health has explored the prevalence and predictors of such behavior in a rural community setting. … READ MORE …